Unigen Revenue and Competitors

USA

Location

N/A

Total Funding

Consumer

Industry

Estimated Revenue & Valuation

  • Unigen's estimated annual revenue is currently $7.8M per year.(i)
  • Unigen's estimated revenue per employee is $200,800

Employee Data

  • Unigen has 39 Employees.(i)
  • Unigen grew their employee count by -51% last year.

Unigen's People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
President &CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
VP Clinical Research and Regulatory ComplianceReveal Email/Phone
5
VP, Sales & MarketingReveal Email/Phone
6
Head FinanceReveal Email/Phone
7
National Sales Director, NutritionalsReveal Email/Phone
8
Marketing ManagerReveal Email/Phone
9
QC ManagerReveal Email/Phone
10
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.1M6716%N/AN/A
#2
$32.9M1319%N/AN/A
#3
$180.4M57528%N/AN/A
#4
$144.1M452-4%$85.8MN/A
#5
$16.7M7421%N/AN/A
#6
$5.1M294%N/AN/A
#7
$445.5M140-7%$8.7MN/A
#8
$39.2M14229%N/AN/A
#9
$266.3M0N/A$497MN/A
#10
$34.9M1396%N/AN/A
Add Company

What Is Unigen?

From discovery to distribution, Unigen is dedicated to the development of botanical and marine-derived therapeutic compounds that address consumer health needs and improve quality of life. Established in 1996, our research and discovery process includes extensive testing at the genetic, cellular, and human clinical levels. Unigen is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. With a core of scientifically substantiated natural ingredients already distribute worldwide, we continue to push the boundaries of pharmaceutical quality research and novel applications for natural products. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$7.8M

Revenue (est)

-51%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.9M393%N/A
#2
$7.6M395%N/A
#3
$9.5M395%N/A
#4
$4.7M39-5%N/A
#5
$15M398%N/A